Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Sep 17;13(9):804. doi: 10.3390/pathogens13090804

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Expected annual polio cases for global bivalent OPV (bOPV) cessation in 2027 and outbreak response for type 2 using novel OPV (nOPV) with either nOPV2 best or nOPV2 worst from 2022 on, and outbreak response for type 1 or 3 using Sabin-strain bOPV until 2027, and then either homotypic nOPV best or nOPV worst (see text and prior studies [48,49] for assumed characteristics of nOPV best and nOPV worst bounds) after bOPV cessation without (baseline) and with additional preventive supplemental immunization activities using bOPV (i.e., intensification) added in some model subpopulations (see text and Figure 1).